MARÍA PILAR GARCÍA ALFONSO-rekin lankidetzan egindako argitalpenak (2)

2013

  1. Clinical significance of VEGFR-2 and 18F-FDG PET/CT SUVmax pretreatment score in predicting the long-term outcome of patients with locally advanced rectal cancer treated with neoadjuvant therapy

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 40, Núm. 11, pp. 1635-1644

2010

  1. 18F-FDG PET bio-metabolic monitoring of neoadjuvant therapy effects in rectal cancer: Focus on nodal disease characteristics

    Radiotherapy and Oncology, Vol. 97, Núm. 2, pp. 212-216